8-KItem 1.01 · Material AgreementItem 1.02 · Termination of AgreementItem 2.03 · Financial ObligationItem 9.01 · Financial Statements
8‑K (Item 9.01): Boston Scientific ($BSX) on Feb 26, 2026 filed three credit agreements — two Credit…
Filed with the SEC on · Summarized by InvestorsBot
8‑K (Item 9.01): Boston Scientific ($BSX) on Feb 26, 2026 filed three credit agreements — two Credit Agreements (Exs. 10.1 & 10.2) and a Term Loan Credit Agreement (Ex. 10.3) — among BSX, the lenders and Wells Fargo Bank, N.A. as administrative agent. 📄🏦 #debt #liquidity
Exhibits include the three credit docs and an Inline XBRL cover page (Ex. 104). 8‑K signed Feb 26, 2026 by Susan Thompson, VP & Chief Corporate Counsel. Investors should review the agreements for terms that could affect leverage and liquidity. $BSX 🔎 #credit #investing